Skip to main content
. 2009 Feb 11;13(8b):2271–2281. doi: 10.1111/j.1582-4934.2009.00693.x

Figure 7.

Figure 7

Development of specific and long‐term antitumour immune response. Recovered mice (n= 5) from p‐c treated group in MethA model were re‐challenged with 1 × 106 parental MethA cells (□) or 3 × 105 irrelevant syngeneic CT26 (▴)tumour cells in the left flank, the mice re‐challenged with CT26 developed large flank tumours and died soon, whereas none of mice re‐challenged with MethA had detectable flank tumours and all the mice survived healthily.